A carregar...
GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder
Bipolar disorder is a serious psychiatric condition that has been treated for over fifty years with lithium. Lithium is a well established glycogen synthase kinase-3 (GSK-3) inhibitor, suggesting that manipulating GSK-3 may have therapeutic value in treating bipolar disorder. GSK-3 is regulated by a...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2020444/ https://ncbi.nlm.nih.gov/pubmed/17499358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neubiorev.2007.03.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|